BARD1 Life Sciences Limited pleased to welcome two new highly credentialed Board members, Mr. Max Johnston and Mr. Philip Powell, effective immediately. Both Mr. Johnston and Mr. Powell intend to participate in the capital raising measures via partially underwriting the entitlement offer as further detailed in this announcement. Max Johnston held the position of President and Chief Executive Officer of Johnson & Johnson Pacific, a division of the world's medical, pharmaceutical and consumer healthcare company for 11 years. Prior to joining Johnson & Johnson, Mr. Johnston's career also included senior roles with Diageo and Unilever in Australia, Africa and Europe. Powell is currently a Non-Executive Director of PolyNovo Ltd. As part of the renewal process, Brett Montgomery has resigned from the Board with immediate effect.